Dömling Alexander, Gao Li
Department of Pharmacy, Drug Design Group, University of Groningen, A. Deusinglaan 1, 9713 Groningen, the Netherlands.
FORTH, Institute of Molecular Biology and Biotechnology, Crete, Greece.
Chem. 2020 Jun 11;6(6):1283-1295. doi: 10.1016/j.chempr.2020.04.023. Epub 2020 May 22.
SARS-CoV-2 (previously 2019-nCoV or Wuhan coronavirus) caused an unprecedented fast-spreading worldwide pandemic. Although currently with a rather low mortality rate, the virus spread rapidly over the world using the modern world's traffic highways. The coronavirus (CoV) family members were responsible for several deadly outbreaks and epidemics during the last decade. Not only governments but also the scientific community reacted promptly to the outbreak, and information is shared quickly. For example, the genetic fingerprint was shared, and the 3D structure of key proteins was rapidly solved, which can be used for the discovery of potential treatments. An overview is given on the current knowledge of the spread, disease course, and molecular biology of SARS-CoV-2. We discuss potential treatment developments in the context of recent outbreaks, drug repurposing, and development timelines.
严重急性呼吸综合征冠状病毒2(之前称为2019新型冠状病毒或武汉冠状病毒)引发了一场前所未有的在全球迅速传播的大流行。尽管目前死亡率相当低,但该病毒利用现代世界的交通网络在全球迅速传播。在过去十年中,冠状病毒家族成员曾导致数次致命的疫情爆发。不仅各国政府,科学界也迅速对此次疫情做出反应,信息得以快速共享。例如,病毒的基因指纹被分享,关键蛋白的三维结构也迅速得到解析,这些可用于发现潜在的治疗方法。本文概述了目前关于严重急性呼吸综合征冠状病毒2的传播、病程及分子生物学的知识。我们在近期疫情爆发、药物重新利用及研发时间表的背景下讨论潜在的治疗进展。